Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Viemed Healthcare (VMD) EBIT Margin (2018 - 2025)

Historic EBIT Margin for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to 7.85%.

  • Viemed Healthcare's EBIT Margin fell 18600.0% to 7.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 8.25%, marking a year-over-year increase of 4400.0%. This contributed to the annual value of 7.98% for FY2024, which is 1500.0% up from last year.
  • Latest data reveals that Viemed Healthcare reported EBIT Margin of 7.85% as of Q3 2025, which was down 18600.0% from 8.08% recorded in Q2 2025.
  • Viemed Healthcare's EBIT Margin's 5-year high stood at 14.6% during Q4 2021, with a 5-year trough of 3.01% in Q2 2022.
  • Over the past 5 years, Viemed Healthcare's median EBIT Margin value was 7.85% (recorded in 2025), while the average stood at 7.72%.
  • Per our database at Business Quant, Viemed Healthcare's EBIT Margin plummeted by -202800bps in 2021 and then surged by 44100bps in 2023.
  • Over the past 5 years, Viemed Healthcare's EBIT Margin (Quarter) stood at 14.6% in 2021, then tumbled by -35bps to 9.42% in 2022, then grew by 11bps to 10.42% in 2023, then grew by 2bps to 10.63% in 2024, then fell by -26bps to 7.85% in 2025.
  • Its EBIT Margin stands at 7.85% for Q3 2025, versus 8.08% for Q2 2025 and 6.5% for Q1 2025.